| UniProt ID | MOD5_HUMAN | |
|---|---|---|
| UniProt AC | Q9H3H1 | |
| Protein Name | tRNA dimethylallyltransferase | |
| Gene Name | TRIT1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 467 | |
| Subcellular Localization |
Isoform 1: Mitochondrion . Isoform 4: Mitochondrion . Isoform 2: Cytoplasm . Isoform 3: Cytoplasm . Isoform 5: Cytoplasm . |
|
| Protein Description | Catalyzes the transfer of a dimethylallyl group onto the adenine at position 37 of both cytosolic and mitochondrial tRNAs, leading to the formation of N6-(dimethylallyl)adenosine (i(6)A).. | |
| Protein Sequence | MASVAAARAVPVGSGLRGLQRTLPLVVILGATGTGKSTLALQLGQRLGGEIVSADSMQVYEGLDIITNKVSAQEQRICRHHMISFVDPLVTNYTVVDFRNRATALIEDIFARDKIPIVVGGTNYYIESLLWKVLVNTKPQEMGTEKVIDRKVELEKEDGLVLHKRLSQVDPEMAAKLHPHDKRKVARSLQVFEETGISHSEFLHRQHTEEGGGPLGGPLKFSNPCILWLHADQAVLDERLDKRVDDMLAAGLLEELRDFHRRYNQKNVSENSQDYQHGIFQSIGFKEFHEYLITEGKCTLETSNQLLKKGIEALKQVTKRYARKQNRWVKNRFLSRPGPIVPPVYGLEVSDVSKWEESVLEPALEIVQSFIQGHKPTATPIKMPYNEAENKRSYHLCDLCDRIIIGDREWAAHIKSKSHLNQLKKRRRLDSDAVNTIESQSVSPDHNKEPKEKGSPGQNDQELKCSV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MASVAAARAV -----CCCHHHHHCC | 15.81 | - | |
| 14 | Phosphorylation | ARAVPVGSGLRGLQR HHCCCCCCCHHHHHH | 34.58 | - | |
| 103 | Phosphorylation | VDFRNRATALIEDIF EECCHHHHHHHHHHH | 20.82 | 19060867 | |
| 137 | Phosphorylation | LWKVLVNTKPQEMGT HHHHHCCCCCHHCCC | 36.30 | 28464451 | |
| 138 | Ubiquitination | WKVLVNTKPQEMGTE HHHHCCCCCHHCCCH | 39.23 | - | |
| 142 | Sulfoxidation | VNTKPQEMGTEKVID CCCCCHHCCCHHEEC | 7.29 | 21406390 | |
| 146 | Ubiquitination | PQEMGTEKVIDRKVE CHHCCCHHEECEEEE | 44.31 | - | |
| 164 | Ubiquitination | EDGLVLHKRLSQVDP CCCEEEEEHHHHCCH | 51.37 | - | |
| 167 | Phosphorylation | LVLHKRLSQVDPEMA EEEEEHHHHCCHHHH | 31.99 | 28985074 | |
| 173 | Sulfoxidation | LSQVDPEMAAKLHPH HHHCCHHHHHHCCCC | 5.52 | 21406390 | |
| 176 | Ubiquitination | VDPEMAAKLHPHDKR CCHHHHHHCCCCCHH | 37.48 | - | |
| 272 | Phosphorylation | QKNVSENSQDYQHGI CCCCCCCCHHHCCCH | 22.00 | - | |
| 297 | Ubiquitination | EYLITEGKCTLETSN HHHHCCCCEEHHHHH | 20.15 | - | |
| 315 | Ubiquitination | KKGIEALKQVTKRYA HHHHHHHHHHHHHHH | 50.17 | - | |
| 315 | Acetylation | KKGIEALKQVTKRYA HHHHHHHHHHHHHHH | 50.17 | 30593099 | |
| 391 | Ubiquitination | PYNEAENKRSYHLCD CCCHHCCCCCHHHHH | 33.94 | - | |
| 431 | Phosphorylation | KKRRRLDSDAVNTIE HHHHCCCHHHHHHHH | 31.87 | 28176443 | |
| 436 | Phosphorylation | LDSDAVNTIESQSVS CCHHHHHHHHHCCCC | 21.37 | 28176443 | |
| 439 | Phosphorylation | DAVNTIESQSVSPDH HHHHHHHHCCCCCCC | 24.73 | 23401153 | |
| 441 | Phosphorylation | VNTIESQSVSPDHNK HHHHHHCCCCCCCCC | 33.57 | 30266825 | |
| 443 | Phosphorylation | TIESQSVSPDHNKEP HHHHCCCCCCCCCCC | 29.83 | 29255136 | |
| 455 | Phosphorylation | KEPKEKGSPGQNDQE CCCCCCCCCCCCCCC | 36.60 | 23401153 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MOD5_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MOD5_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MOD5_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SMYD3_HUMAN | SMYD3 | physical | 23455924 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-443, AND MASSSPECTROMETRY. | |
| "Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction."; Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.; Mol. Cell. Proteomics 6:1952-1967(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-103, AND MASSSPECTROMETRY. | |